BRPI0804518A2 - método de controle de uma população de cães - Google Patents
método de controle de uma população de cães Download PDFInfo
- Publication number
- BRPI0804518A2 BRPI0804518A2 BRPI0804518-6A BRPI0804518A BRPI0804518A2 BR PI0804518 A2 BRPI0804518 A2 BR PI0804518A2 BR PI0804518 A BRPI0804518 A BR PI0804518A BR PI0804518 A2 BRPI0804518 A2 BR PI0804518A2
- Authority
- BR
- Brazil
- Prior art keywords
- dog
- dogs
- population
- controlling
- freely
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Feed For Specific Animals (AREA)
Abstract
MéTODO DE CONTROLE DE UMA POPULAçãO DE CãES. Trata-se de um método de controle de uma população de cães com a composição química para o uso no controle da população de cães machos sexualmente maduros que perambulam livremente. O esterilizador químico é injetado de uma maneira que a aparência e as características sexuais masculinas secundárias do cão sejam preservadas de maneira tal que o cão mantenha a sua posição na hierarquia dos cães que perambulam livremente enquanto não contribui com o número dos filhotes de cães produzidos. Uma redução ao número de cães que perambulam livremente reduz o número de vítimas humanas da raiva adquirida por mordida de cão. Devido ao fato que a aparência e a natureza do cão esterilizado ficam substancialmente inalteradas, a composição química é aceitável para a comunidade humana que o cão habita.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/863,758 US20090088471A1 (en) | 2007-09-28 | 2007-09-28 | Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies |
| PCT/US2008/011187 WO2009045337A1 (en) | 2007-09-28 | 2008-09-26 | Chemical sterilant for adult male dog population control, comprising a mineral gluconate and an amino acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0804518A2 true BRPI0804518A2 (pt) | 2011-08-30 |
Family
ID=40089865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0804518-6A BRPI0804518A2 (pt) | 2007-09-28 | 2008-09-26 | método de controle de uma população de cães |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090088471A1 (pt) |
| EP (1) | EP2192897A1 (pt) |
| CN (1) | CN101888838A (pt) |
| AR (1) | AR068581A1 (pt) |
| BR (1) | BRPI0804518A2 (pt) |
| CL (1) | CL2008002909A1 (pt) |
| CO (1) | CO6270316A2 (pt) |
| MX (1) | MX2010003474A (pt) |
| PA (1) | PA8797601A1 (pt) |
| PE (1) | PE20091031A1 (pt) |
| RU (1) | RU2455000C2 (pt) |
| WO (1) | WO2009045337A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2823592C (en) | 2011-01-03 | 2021-11-23 | The Regents Of The University Of California | High density epidural stimulation for facilitation of locomotion, posture, voluntary movement, and recovery of autonomic, sexual, vasomotor, and cognitive function after neurological injury |
| US9393409B2 (en) | 2011-11-11 | 2016-07-19 | Neuroenabling Technologies, Inc. | Non invasive neuromodulation device for enabling recovery of motor, sensory, autonomic, sexual, vasomotor and cognitive function |
| RS58781B1 (sr) * | 2012-08-23 | 2019-06-28 | Senestech Inc | Kompozicije i postupci za redukciju reproduktivnog kapaciteta ženki pacova |
| US20140271716A1 (en) | 2013-03-15 | 2014-09-18 | Ark Sciences, Inc. | Intra-testicular Injection of Immunogens |
| WO2014144785A1 (en) | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion |
| CA2925754C (en) | 2013-09-27 | 2023-02-21 | The Regents Of The University Of California | Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects |
| US11097122B2 (en) | 2015-11-04 | 2021-08-24 | The Regents Of The University Of California | Magnetic stimulation of the spinal cord to restore control of bladder and/or bowel |
| WO2018148844A1 (en) | 2017-02-17 | 2018-08-23 | The University Of British Columbia | Apparatus and methods for maintaining physiological functions |
| US12434068B2 (en) | 2017-05-23 | 2025-10-07 | The Regents Of The University Of California | Accessing spinal networks to address sexual dysfunction |
| DE20168827T1 (de) | 2017-06-30 | 2021-01-21 | Gtx Medical B.V. | System zur neuromodulierung |
| US11992684B2 (en) | 2017-12-05 | 2024-05-28 | Ecole Polytechnique Federale De Lausanne (Epfl) | System for planning and/or providing neuromodulation |
| US12357828B2 (en) | 2017-12-05 | 2025-07-15 | Ecole Polytechnique Federale De Lausanne (Epfl) | System for planning and/or providing neuromodulation |
| US12478777B2 (en) | 2018-08-23 | 2025-11-25 | The Regents Of The University Of California | Non-invasive spinal cord stimulation for nerve root palsy, cauda equina syndrome, and restoration of upper extremity function |
| EP3653256B1 (en) | 2018-11-13 | 2022-03-30 | ONWARD Medical N.V. | Control system for movement reconstruction and/or restoration for a patient |
| EP3695878B1 (en) | 2019-02-12 | 2023-04-19 | ONWARD Medical N.V. | A system for neuromodulation |
| EP3972683A4 (en) | 2019-05-22 | 2023-11-08 | The Regents Of The University Of California | TRANSCUTANEOUS ELECTRICAL SPINAL CORD NEUROMODULATOR AND USES THEREOF |
| EP3824948A1 (en) | 2019-11-19 | 2021-05-26 | ONWARD Medical B.V. | A planning and/or control system for a neuromodulation system |
| DE19211738T1 (de) | 2019-11-27 | 2021-09-09 | Onward Medical B.V. | Neuromodulationssystem |
| EP3827871A1 (en) | 2019-11-27 | 2021-06-02 | ONWARD Medical B.V. | Neuromodulation system |
| US12623080B2 (en) | 2023-06-21 | 2026-05-12 | Onward Medical N.V. | Neuromodulation system |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4339438A (en) * | 1976-01-23 | 1982-07-13 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4156427A (en) * | 1976-01-23 | 1979-05-29 | The Curators Of The University Of Missouri | Injectable male animal sterilant for selectively controlling the function of testes |
| US4937234A (en) * | 1988-08-10 | 1990-06-26 | Fahim Mostafa S | Minerals in bioavailable form |
| US5070080A (en) * | 1988-08-10 | 1991-12-03 | Fahim Mostafa S | Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form |
| US5372822A (en) * | 1994-03-07 | 1994-12-13 | Fahim; Mostafa S. | Chemical castration |
| US7125385B1 (en) * | 2003-04-14 | 2006-10-24 | Technology Transfer, Inc. | Instrument for determining intratesticular dose and method for determining a dose |
| US7276535B1 (en) * | 2003-04-14 | 2007-10-02 | Technology Transfer, Inc. | Intratesticular injection of chemical sterilant |
-
2007
- 2007-09-28 US US11/863,758 patent/US20090088471A1/en not_active Abandoned
-
2008
- 2008-09-26 MX MX2010003474A patent/MX2010003474A/es not_active Application Discontinuation
- 2008-09-26 RU RU2010116777/15A patent/RU2455000C2/ru not_active IP Right Cessation
- 2008-09-26 EP EP08836134A patent/EP2192897A1/en not_active Ceased
- 2008-09-26 WO PCT/US2008/011187 patent/WO2009045337A1/en not_active Ceased
- 2008-09-26 BR BRPI0804518-6A patent/BRPI0804518A2/pt not_active IP Right Cessation
- 2008-09-26 CN CN2008801165663A patent/CN101888838A/zh active Pending
- 2008-09-29 AR ARP080104252A patent/AR068581A1/es unknown
- 2008-09-29 PA PA20088797601A patent/PA8797601A1/es unknown
- 2008-09-29 CL CL2008002909A patent/CL2008002909A1/es unknown
- 2008-09-29 PE PE2008001695A patent/PE20091031A1/es not_active Application Discontinuation
-
2010
- 2010-04-28 CO CO10050344A patent/CO6270316A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010003474A (es) | 2010-08-04 |
| EP2192897A1 (en) | 2010-06-09 |
| RU2455000C2 (ru) | 2012-07-10 |
| PA8797601A1 (es) | 2010-05-26 |
| CO6270316A2 (es) | 2011-04-20 |
| CL2008002909A1 (es) | 2009-09-04 |
| CN101888838A (zh) | 2010-11-17 |
| US20090088471A1 (en) | 2009-04-02 |
| AR068581A1 (es) | 2009-11-18 |
| RU2010116777A (ru) | 2011-11-10 |
| WO2009045337A1 (en) | 2009-04-09 |
| PE20091031A1 (es) | 2009-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010003474A (es) | Esterilizante quimico para control de poblacion de perros macho adultos, que comprende un gluconato mineral y un aminoacido. | |
| CL2010001260A1 (es) | Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis. | |
| BRPI0416881A (pt) | método para reduzir odor excrementos de um animal doméstico. | |
| UY26269A1 (es) | Formulación de sal común y moxifloxacina | |
| BRPI0925036B8 (pt) | uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele | |
| HN1999000183A (es) | Preparado farmaceuticos de moxifloxacina | |
| ECSP056138A (es) | Dihidroquinazolinas sustituidas | |
| BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
| TW200505425A (en) | Compositions and method for treating infection in cattle and swine | |
| UY30762A1 (es) | Sal fumarato de (alfa s, beta r)-6-bromo-alfa-[2(dimetilamino) etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol | |
| WO2009055799A3 (en) | Compositions and methods for treatment of diseases of the foot of an animal | |
| AR043824A1 (es) | Composiciones y metodo para tratar las infecciones microbianas y parasitarias en el ganado y otros animales | |
| ES2194535T3 (es) | 4-trifluorometil-3-oxazolilpiridinas, procedimiento para su preparacion, agentes que las contien y su uso como agente parala lucha contra organismos dañinos. | |
| AU2002231889A1 (en) | Halogenated composition, method for preparing same and uses thereof | |
| GT200400220A (es) | Productos para las axilas con componente superabsorbente. | |
| UY28313A1 (es) | Nonadepsipeptidos acilados | |
| BRPI0617077A2 (pt) | Agente terapêutico para tratamento de doenças do fígado contendo 2-amina-1, 3-propanediol derivativo como ingrediente ativo, e método para tratamento de doenças do fígado | |
| BRPI0408499A (pt) | solução aquosa estável de um fungicida de polieno | |
| AR052855A1 (es) | Composiciones para el cuidado bucal que contienen un extrato de eucalyptus | |
| SV2006002290A (es) | Nonadepsipeptidos acilados ii ref. bhc041327-sv | |
| BRPI0418764A (pt) | uso de espinosina ou um derivado ou sal da mesma fisiologicamente aceitável | |
| CL2009000987A1 (es) | Composición de alimentación que comprende peptidoglicano y nucleotidos; y su uso para la profilaxis y/o tratamiento de enfermedades infecciosas en animales. | |
| BR112012015170A2 (pt) | "derivado de amino-heteroarila, composição farmacêutica, uso de um derivado de amino-heteroarila, e, método para tratamento de dor." | |
| BRPI0907224A2 (pt) | formulações narcórticas em emulsão para tratamento de dor cirúrgica | |
| BR0210063A (pt) | Composição estável e uso da mesma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2325 DE 28-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |